Skip to content

Strain Echocardiography During Septic Shock : an Observational Pilot Study

Strain Echocardiography During Septic Shock : an Observational Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03663192
Acronym
Sepsistrain
Enrollment
50
Registered
2018-09-10
Start date
2016-02-22
Completion date
2018-03-31
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Echocardiography, Shock, Septic

Keywords

Shock, Septic, Echocardiography, speckle tracking, strain

Brief summary

The mortality of septic shock remains high nowadays despite a trend toward improvement.Septic cardiomyopathy has been reported in most experimental models of sepsis shock. Its relationship with mortality is unclear. A decrease in mortality have been reported in patients with decreased left ventricular ejection fraction (LVEF), but a recent meta-analysis did not support such results. In fact, it appears that high LVEF are linked to profound vasoplegia which is associated to bad outcome. In the other hand, alterations of Strain echocardiography, a new method allowing a more sensitive evaluation of heart function, have been associated with a worse outcome in sepsis patients. Only few studies have examined echocardiographic strain during sepsis shock in human, and its natural history was only described in pigs. Moreover, the right ventricular strain was reported only by Orde et al whereas the evolution of strain during fluid infusion have never been studied. The aim of the present study is to describe the natural history of echocardiographic strain during sepsis shock and to determine its prognosis value.

Interventions

strain echocardiography during septic shock

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Septic shock (suspected or proven infection and norepinephrine ≥ 0,25µg/kg/min) * Inclusion within the first 24h of septic shock

Exclusion criteria

* Patient \< 18 year of age * Pregnant women * History of myocardial infarction, valvular disease, atrial fibrillation

Design outcomes

Primary

MeasureTime frame
Global peak systolic longitudinal strain assessed by echocardiography. Global peak systolic longitudinal strainup to 90 days

Secondary

MeasureTime frameDescription
ICU mortalityup to 90 daysOn the day of patient discharge from the ICU

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026